Physician profile
Yared Terefe
NPI 1811104425
$879.59
in general payments reported to CMS, 2019-2025
17 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $142 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $154.98 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $118.97 | 2019-2020 | |
| Pfizer INC. | $118.15 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $54.87 | 2019-2020 | |
| Ucb, INC. | $50.48 | 2019 | |
| Mylan Specialty L.P. | $49.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.52 | 2019 | |
| Amgen INC. | $44.80 | 2019 | |
| Insmed, INC. | $44.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.15 | 2019-2020 | |
| Vifor Pharma, INC. | $38.88 | 2019 | |
| Astellas Pharma US INC | $28.45 | 2019 | |
| Allergan, INC. | $23.67 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $19.44 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.82 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.50 | 2020 | |
| Biomerieux INC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yared Terefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.